Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05187013 · ClinicalTrials.gov registry record · NA
Uncontrolled Hypertension Among the Homeless
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 123
- Enrollment target
NCT05187013 is a NA study that has completed, run by George Washington University. The registered enrollment target is 123 participants.
The verdict
NCT05187013, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
Study Summary
This study is designed to assess the effect of implementing a mobile health (mHealth) strategy using text messaging for hypertension (HTN) management among hypertensive homeless persons with uncontrolled blood pressure age 21 or older in shelter-clinics in New York City (NYC). The study uses a randomized clinical trial design (homeless, n=120) and semi-structured interviews (homeless, n=30; providers, n=20). The control group will receive text messages for usual standard care/healthy lifestyle during a 6-month follow-up period. The intervention group will receive text messages geared towards both standard care/healthy lifestyle and blood pressure control. At the end of study period, the investigators will assess changes in blood pressure (BP) measurements, adherence to clinic visits, and adherence to medication, and the investigators will compare them between the two groups. Qualitative interviews with both patients and providers who provide services to the homeless in shelter settings will develop a better understand barriers and opportunities regarding BP control. The investigators hypothesize that those individuals randomized to the intervention will experience a reduction in blood pressure (8mmHg systolic BP or diastolic BP) and will exhibit better adherence to blood pressure medications and appointments compared to the control group.
Interventions
- BEHAVIORAL mHealth for Hypertension in Homeless Persons
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2025-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05187013
The ClinicalTrials.gov registry entry for NCT05187013 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which mHealth for Hypertension in Homeless Persons is the first listed.
NCT05187013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05187013 about?
NCT05187013 is a clinical study titled "Uncontrolled Hypertension Among the Homeless". This study is designed to assess the effect of implementing a mobile health (mHealth) strategy using text messaging for hypertension (HTN) management among hypertensive homeless persons with uncontrolled blood pressure age 21 or older in shelter-clinics in New York City (NYC). The study uses a rando...
What is the current status of trial NCT05187013?
This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2022-09-12. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT05187013?
The interventions under investigation include: mHealth for Hypertension in Homeless Persons (BEHAVIORAL).
Who is sponsoring clinical trial NCT05187013?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.